Dongchuan Guo Guo

Prof. Dongchuan Guo Guo

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2006 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DGDongchuan Guo Guo
Dongchuan Guo Guo
CPChristina L. Papke
Christina L. Papke
RHRumin He
Rumin He
DMDianna M. Milewicz
Dianna M. Milewicz

12 June 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
DKDerek Klarin
Derek Klarin
PDPoornima Devineni
Poornima Devineni
ASAnoop K. Sendamarai
Anoop K. Sendamarai
AAAnthony R. Angueira
Anthony R. Angueira
SGSarah E. Graham
Sarah E. Graham
SDScott M. Damrauer
Scott M. Damrauer
The current understanding of the genetic determinants of thoracic aortic aneurysms and dissections (TAAD) has largely been informed through studies of rare, Mendelian forms of disease. Here, we conducted a genome-wide association study (GWAS) of TAAD, testing ~25 million DNA sequence variants in 8,626 participants with and 453,043 participants without TAAD in the Million Veteran Program, with replication in an independent sample of 4,459 individuals with and 512,463 without TAAD from six cohorts. We identified 21 TAAD risk loci, 17 of which have not been previously reported. We leverage multiple downstream analytic methods to identify causal TAAD risk genes and cell types and provide human genetic evidence that TAAD is a non-atherosclerotic aortic disorder distinct from other forms of vascular disease. Our results demonstrate that the genetic architecture of TAAD mirrors that of other complex traits and that it is not solely inherited through protein-altering variants of large effect size.

2 September 2024 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SMSara Mansoorshahi
Sara Mansoorshahi
Angela YetmanAngela Yetman
Angela Yetman
MBMalenka M. Bissell
Malenka M. Bissell
YKYuli Y. Kim
Yuli Y. Kim
HMHector I. Michelena
Hector I. Michelena
SPSiddharth Prakash
Siddharth Prakash

7 April 2026 in Circulation
Verified
Journal Article
Closed access
STSébastien Thériault
Sébastien Thériault
JHJacob A. Holdcraft
Jacob A. Holdcraft
DSDinara Sharipova
Dinara Sharipova
Adèle FaucherreAdèle Faucherre
Adèle Faucherre
RDRadoslaw M. Debiec
Radoslaw M. Debiec
SBSimon Body
Simon Body
BACKGROUND: Bicuspid aortic valve (BAV) is a frequent congenital heart defect with a high heritability. Despite this, only a limited number of genes have been associated with the disease, and the molecular mechanisms remain unexplained in most cases. This study aimed to further understand the genetic architecture of BAV. METHODS: A genome-wide association study meta-analysis including 9631 cases among 65 677 participants was performed. Genes were prioritized using transcriptomic analyses based on RNA sequencing in relevant tissues, including human fetal and adult aortic valves. The impact of the knockdown or knockout of 4 candidate genes on cardiac development was verified in zebrafish. A polygenic risk score was developed, its association with BAV was evaluated in an independent cohort, and its association with a wide range of phenotypes (n=976) was evaluated in UK Biobank (n=355 618 individuals). RESULTS: Thirty-six genomic loci were identified, including 32 that were not described previously. Among the prioritized genes, KANK2 and ERBB4 were identified as potentially causal through transcriptomic analyses, colocalization, and Mendelian randomization based on gene expression in human aortic valves (n=484), whereas PRDM6 and STRN were prioritized using similar analyses from aortic (n=326) and left ventricular tissues (n=326), respectively. Targeting 4 candidate genes ( WNT4 , LEF1 , STRN , and KANK2 ) in zebrafish led to disruption in cardiac development. A polygenic risk score was associated with an odds ratio of 2.07 (95% CI, 1.90–2.25; P =5.43×10 -62 ) per SD for BAV and significantly associated with thoracic aortic aneurysm and atrial fibrillation in UK Biobank. CONCLUSIONS: This study supports a significant polygenic contribution to BAV, where the combination of multiple common variants in genes involved in heart morphogenesis disrupts aortic valve development.

7 March 2023 in Clinical Genetics
Verified
Journal Article
Closed access
DGDongchuan Guo Guo
Dongchuan Guo Guo
XDXueyan Duan
Xueyan Duan
KMKathleen Mimnagh
Kathleen Mimnagh
ACAlana C. Cecchi
Alana C. Cecchi
IMIsabella C. Marin
Isabella C. Marin
DMDianna M. Milewicz
Dianna M. Milewicz

9 December 2024 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
MLMichelle Su-Anne Lim
Michelle Su-Anne Lim
DGDongchuan Guo Guo
Dongchuan Guo Guo
WTWalter Velasco Torrez
Walter Velasco Torrez
ALAndrew Lai
Andrew Lai
JSJonathan Schweber
Jonathan Schweber
ABAlan C Braverman
Alan C Braverman
Background: Pathogenic variants inTGFB3may lead to a syndromic genetic aortopathy. Heritable thoracic aortic disease (HTAD) and arterial events may occur inTGFB3-related disease but there are limited outcomes data on vascular events in this condition.Methods: Clinical data, phenotypical features and aortic outcomes in individuals with pathogenic/likely pathogenic (P/LP)TGFB3variants enrolled in the Montalcino Aortic Consortium registry were reviewed.Results: 34 individuals (56% male, median age 42 years, IQR 17–49, range 3–74 years) with P/LPTGFB3variants were studied. Craniofacial, cutaneous and musculoskeletal features seen in Loeys-Dietz syndrome were variably present. Extra-aortic cardiovascular features included arterial tortuosity (25%), extra-aortic arterial aneurysms (6%) and mitral valve prolapse (21%).Aortic dilation (Z-Score>2) was present in 10 individuals (29%) and aortic dissection occurred in 2 (6%). Type A aortic dissection occurred in two patients (aged between 55 years and 60 years), and one of these patients experienced a type B aortic dissection 6 years later. Seven adults (median age 62 years, range 32–69 years) with aortic root dilation (41–49 mm) are being followed. No patients have undergone prophylactic aortic surgery. Twenty-five per cent of children have aortic dilation. Sixty-eight per cent of the entire cohort remains free of aortic disease. No deaths have occurred.Conclusions: TGFB3-related HTAD is characterised by late-onset and less penetrant thoracic aortic and arterial disease compared with other transforming growth factor β HTAD. Based on our data, a larger aortic size threshold for prophylactic aortic surgery is appropriate in patients withTGFB3-related HTAD compared with HTAD due toTGFBR1orTGFBR2variants.